THE USE OF PROBIOTIC BACTERIA IN THE MANUFACTURE OF A COMPOSITION FOR ADMINISTRATION TO A WOMAN IN AT LEAST THE THIRD TRIMESTER OF PREGNANCY FOR PREVENTION OF GESTATIONAL DIABETES, NORMALISING PLASMA GLUCOSE CONCENTRATION AND/OR INCREASING INSULIN SENSITIVITY. MOST ILLUSTRATIVE FIGURE: FIGURE 1